Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,170 | 99 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $791.88 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $613.43 | 10 | $0 (2024) |
| ABBVIE INC. | $611.78 | 20 | $0 (2024) |
| Novo Nordisk Inc | $530.66 | 15 | $0 (2024) |
| Abbott Laboratories | $443.92 | 5 | $0 (2024) |
| Amgen Inc. | $341.73 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $214.50 | 7 | $0 (2023) |
| Intuity Medical Inc | $142.62 | 2 | $0 (2023) |
| ITI, Inc. | $124.91 | 1 | $0 (2023) |
| Melinta Therapeutics, LLC | $124.91 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,094 | 46 | AstraZeneca Pharmaceuticals LP ($469.07) |
| 2023 | $1,331 | 33 | Lilly USA, LLC ($217.82) |
| 2022 | $718.28 | 18 | Novo Nordisk Inc ($212.86) |
| 2021 | $26.06 | 2 | Novo Nordisk Inc ($13.58) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $119.21 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $132.25 | General |
| Category: Diabetes Care | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $138.28 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Diabetes Care | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $102.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $107.72 | General |
| Category: Diabetes Care | ||||||
| 08/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Biological | ||||||
| 07/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $44.45 | General |
| Category: Diabetes Care | ||||||
| 07/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $115.43 | General |
| Category: Diabetes | ||||||
| 06/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Respiratory | ||||||
| 05/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $120.98 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 156 | 291 | $51,218 | $15,241 |
| 2022 | 5 | 140 | 214 | $29,365 | $12,968 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 131 | $29,754 | $8,523 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 84 | $14,530 | $4,136 | 28.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $2,730 | $1,471 | 53.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 11 | 12 | $1,728 | $531.67 | 30.8% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 13 | 13 | $1,300 | $220.56 | 17.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 13 | 13 | $415.00 | $194.35 | 46.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 24 | $761.00 | $164.55 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 77 | $13,550 | $6,251 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 79 | $11,850 | $4,426 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 17 | 17 | $2,600 | $1,827 | 70.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 27 | $945.00 | $253.39 | 26.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 14 | 14 | $420.00 | $211.30 | 50.3% |
About Nora Medina
Nora Medina is a Family healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2021. The National Provider Identifier (NPI) number assigned to this provider is 1023782448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nora Medina has received a total of $4,170 in payments from pharmaceutical and medical device companies, with $2,094 received in 2024. These payments were reported across 99 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($4,170).
As a Medicare-enrolled provider, Medina has provided services to 296 Medicare beneficiaries, totaling 505 services with total Medicare billing of $28,209. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Weslaco, TX
- Active Since 08/09/2021
- Last Updated 08/09/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023782448
Products in Payments
- MOUNJARO (Drug) $387.38
- FARXIGA (Drug) $330.73
- JARDIANCE (Drug) $291.06
- AIRSUPRA (Drug) $267.97
- Rybelsus (Drug) $256.42
- VRAYLAR (Drug) $255.20
- Repatha (Biological) $250.62
- FREESTYLE LIBRE (Device) $239.97
- FREESTYLE LIBRE 3 (Device) $203.95
- UBRELVY (Drug) $202.72
- QULIPTA (Drug) $153.86
- Pogo Automatic Blood Glucose Monitoring System (Device) $142.62
- CAPLYTA (Drug) $124.91
- Kimyrsa (Drug) $124.91
- TRELEGY ELLIPTA (Drug) $92.48
- Otezla (Drug) $91.11
- TRULICITY (Drug) $90.21
- Seglentis (Drug) $85.89
- Ozempic (Drug) $63.66
- Livalo (Drug) $28.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Weslaco
Pamela Lopez, Aprn-Bc, Cde, APRN-BC, CDE
Family — Payments: $17,229
Margarita Rodriguez, Fnp, FNP
Family — Payments: $3,773
Francisco Lugo
Family — Payments: $2,538
Mr. Jesus Guerra, Fnp, FNP
Family — Payments: $2,171
Belinda Aguilar, Fnp-C, FNP-C
Family — Payments: $1,702
Maricela Hernandez, Aprn-Cnp, APRN-CNP
Family — Payments: $1,586